A Study to See How Well Lebrikizumab Works in Adults and Adolescents With Moderate Atopic Dermatitis (Eczema) and High Itch Burden (NCT07006792)
A Phase 4, Multicenter, Open-label, Single-arm Study to Investigate the Efficacy of Lebrikizumab in Adult and Adolescent Participants With Moderate Atopic Dermatitis and High Itch Burden
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this study is to measure how well taking lebrikizumab alone works for participants with fewer places on the body with eczema (atopic dermatitis), but these places may be very itchy. Participation in this study will last up to approximately 38 weeks (9 and a half months) including 24 weeks (6 months) of treatment.
Who can join: Review the eligibility criteria below.
Location: Total Skin & Beauty Dermatology Center, PC DBA Total Dermatology — Birmingham, Alabama
Age range: 12 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (66 Sites)
Showing the first 25 of 66 sites.
- Total Skin & Beauty Dermatology Center, PC DBA Total Dermatology — Birmingham, Alabama
- Research Solutions of Arizona — Litchfield Park, Arizona
- Alliance Dermatology and Mohs Center — Phoenix, Arizona
- California Dermatology & Clinical Research Institute — Encinitas, California
- Dermatology Research Associates — Los Angeles, California
- NorCal Clinical Research — Rocklin, California
- Suncoast Research Associates — Doral, Florida
- Encore Medical Research — Hollywood, Florida
- Solutions Through Advanced Research — Jacksonville, Florida
- Life Arc Research Centers - Miami — Miami, Florida
- MCR Research — Miami, Florida
- Health Clinical Research — Miami, Florida
- Deluxe Health Center — Miami Lakes, Florida
- Renstar Medical Research — Ocala, Florida
- Leading Edge Dermatology — Plantation, Florida
- Dermatology Affiliates Research Institute — Atlanta, Georgia
- DeNova Research — Chicago, Illinois
- Southern Indiana Clinical Research Center — Columbus, Indiana
- Dawes Fretzin Clinical Research Group, LLC — Indianapolis, Indiana
- Southern Indiana Clinical Trials — New Albany, Indiana
- Equity Medical - Bowling Green — Bowling Green, Kentucky
- Allergy & Asthma Specialists, P.S.C. — Owensboro, Kentucky
- Foxhall Research Center — Chevy Chase, Maryland
- Great Lakes Research Group, Inc. — Bay City, Michigan
- Revival Research Institute, LLC — Troy, Michigan
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Atopic Dermatitis
- ATI-045 Versus Placebo in Patients With Moderate-to-Severe Atopic Dermatitis — Phoenix, Arizona
- A Study of Barzolvolimab in Patients With Atopic Dermatitis — Birmingham, Alabama
- Defining the Skin and Blood Biomarkers of Pediatric Atopic Dermatitis — Chicago, Illinois
- A Study of KT-621 Administered Orally to Participants With Moderate to Severe Atopic Dermatitis — Birmingham, Alabama
- A Study Evaluating APG777 in Atopic Dermatitis — Fountain Valley, California
Explore by condition: All Atopic Dermatitis clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.